🇺🇸 FDA
Patent

US 8927275

Differentiation of human embryonic and induced pluripotent stem cells

granted A61PA61P19/00A61P19/02

Quick answer

US patent 8927275 (Differentiation of human embryonic and induced pluripotent stem cells) held by UNIVERSITY OF CONNECTICUT expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P19/00, A61P19/02, A61P19/04, A61P19/08